Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹455.00
Market cap
₹17,408 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
163.9×Sector 47.4×
Promoter holding
57.49%+0.00% QoQ
FII holding
6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:37 IST BSE
Business Update

Cohance Lifesciences Business Update

Cohance Lifesciences completed a USFDA inspection at its Jaggaiahpet API facility, receiving a Form 483 with five observations. The company has initiated corrective and preventive actions.